We have located links that may give you full text access.
Blood Monocyte Frequency May Be a Biomarker for Response to Anti-PD-1.
Cancer Discovery 2018 March
CD14+ CD16- HLA-DRhi monocyte frequency was linked to response to anti-PD-1 in patients with melanoma.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app